NCT00001143 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Dobkins KR, Teller DY
Infant contrast detectors are selective for direction of motion. Vision Res. 1996 Jan;36(2):281-94.
Norcia AM
Abnormal motion processing and binocularity: infantile esotropia as a model system for effects of early interruptions of binocularity. Eye (Lond). 1996;10 ( Pt 2):259-65. Review.
Shupert C, Fuchs AF
Development of conjugate human eye movements. Vision Res. 1988;28(5):585-96. Review.

Ocular Motor Development During the First Seven Months of Life in Infants With and Without a Family History of Strabismus

Clinical trial NCT00001143 - References